During this year Keystone Symposia on Tumor Metabolism (January 21—25, 2018 • Snowbird, Utah USA) our coordinator had the pleasure of meeting another metabolism related H2020-MSCA-ITN project: TRANSMIT – TRANSlating the role of Mitochondria in Tumorigenesis.
TRANSMIT aims to dissect the metabolic remodeling in human cancers, placing the focus on the role of mitochondria and bridging basic research to the improvement/development of therapeutic strategies. Further, TRANSMIT fosters the communication of this emerging field to the patients and their families. To these aims, TRANSMIT has created a network of seven different countries, among which world-leading basic science and clinical centers of excellence, several industrial partners with up-to-date omics technologies, as well as non-profit foundations and associations who care for cancer patients. By creating the critical mass of scientific excellence, TRANSMIT intends to transfer the current knowledge into the wide field of cancer research, translating scientific and technical advances into the education and training of eleven Early Stage Researchers.
We are looking forward to new fruitful collaborations.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.